ArticleJournal of thoracic disease2026
Research trends in cytokine regulation of immunotherapy in non-small cell lung cancer: a bibliometric and BERTopic analysis from 2015 to 2025.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cytokines are key regulators of antitumor immunity in non-small cell lung cancer (NSCLC), particularly in the context of immunotherapy. However, the global knowledge structure and thematic evolution of cytokine-regulated immunotherapy in NSCLC have not been systematically characterized. This study aimed to delineate publication trends, intellectual structures, and evolving research themes in this field from 2015 to 2025. Methods: Publications related to cytokine-regulated immunotherapy in NSCLC were retrieved from the Web of Science Core Collection (WoSCC). Bibliometric analysis combined with Bidirectional Encoder Representations from Transformers-based topic modeling (BERTopic) was used to evaluate publication trends, countries, institutions, authors, journals, co-cited references, keywords, and thematic evolution. Results: A total of 1,186 publications were included, with annual output increasing steadily over the study period. China contributed the largest number of publications, whereas the United States showed greater citation-based impact, as reflected by total citations and H-index. Institutional and authorship analyses identified an internationally connected research network dominated by Chinese institutions and strengthened by cross-national collaboration. Co-citation and journal analyses showed that research during the earlier post-approval period of immune checkpoint inhibitor (ICI) therapy primarily focused on landmark ICI trials, whereas recent studies have increasingly shifted toward mechanistic and translational investigations. Integrated keyword clustering, burst detection, and BERTopic analyses revealed a thematic transition from clinical efficacy-oriented research to more complex domains, including cytokine networks, tumor immune microenvironment (TIME) remodeling, resistance mechanisms, biomarkers, immune evasion, molecular subtyping, and combination strategies. Conclusions: This study maps the knowledge structure and research trajectory of cytokine-related immunotherapy in NSCLC. The findings provide a structured framework for future mechanistic studies and may support the development of more precise and effective immunotherapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.